MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma

An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients

(2011) F. Crea et al.   ANNALS OF ONCOLOGY

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma

(2011) J Buechner et al.   BRITISH JOURNAL OF CANCER

The role of EZH2 in tumour progression

(2011) C-J Chang et al.   BRITISH JOURNAL OF CANCER

MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

(2011) J. Lu et al.   CANCER RESEARCH

Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase

(2011) Assia Derfoul et al.   CARCINOGENESIS

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2

(2011) Fang Zheng et al.   GUT

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98

(2011) N M Alajez et al.   Cell Death & Disease

Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study

(2010) Xueqian Wang et al.   BMC CANCER

MiR-138 inhibits EZH2 methyltransferase expression and methylation of histone H3 at lysine 27, and affects thermotolerance acquisition

(2010) Tatiana Kisliouk et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2

(2010) Daisy PF Tsang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Dysregulation of miR-15a and miR-214 in human pancreatic cancer

(2010) Xing J Zhang et al.   Journal of Hematology & Oncology

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β

(2010) Paul Cao et al.   Molecular Cancer

Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients

(2009) Fangwei Xie et al.   CLINICAL & EXPERIMENTAL METASTASIS

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

(2009) Li-Ru He et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells

(2009) Zuozhen Yang et al.   IUBMB LIFE

MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN

(2008) H. Yang et al.   CANCER RESEARCH

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells

(2008) Antonio Strillacci et al.   EXPERIMENTAL CELL RESEARCH

MicroRNA expression profiles of esophageal cancer

(2008) Andrew Feber et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus

(2008) Ching Tzao et al.   MODERN PATHOLOGY

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas

(2008) Kazunori Kidani et al.   ORAL ONCOLOGY

The let-7 family of microRNAs

(2008) Sarah Roush et al.   TRENDS IN CELL BIOLOGY